Skip to main content

Headlines

Palvella Therapeutics is Now Oversold (PVLA)
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Oversold Conditions For Kailera Therapeutics (KLRA)
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Jasper Therapeutics Consensus Price Target Increased 19.86% to $8.92
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Fulcrum Therapeutics Consensus Price Target Raised 11.22% to $7.75
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Should You Buy Viking Therapeutics Stock While It Trades Below Its $35 Offering Price?
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
NeuroSense Therapeutics Consensus Price Target Increased by 1,507.27% to $112.71
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
BlossomHill Therapeutics Average Analyst Price Target Raised 10.53% to $37.48
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Definium Therapeutics Consensus Price Target Raised 12.21% to $73.32
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Capricor Therapeutics Average Analyst Price Target Rises 12.70% to $24.14
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Spero Therapeutics Consensus Price Target Raised 25% to $5.10
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Axsome Therapeutics vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
HC Wainwright & Co. initiates coverage of Monte Rosa Therapeutics with a Buy rating
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
United Therapeutics (UTHR) Moves 12.6% Higher: Will This Strength Last?
posted:
by: Nasdaq Technology
#channels:: #All, #Business, #Nasdaq, #Technology, #NasdaqTechnology, #Stocks
Pliant Therapeutics Names David Raben As CMO To Lead PLN-101095 Development
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
United Therapeutics Prevails In Patent Litigation Against Liquidia
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks